Possible role of edotecarin, a novel topoisomerase I inhibitor, in therapy-related myelodysplastic syndrome.

Article Details

Citation

Carvajal RD, Ilson DH, Noy A

Possible role of edotecarin, a novel topoisomerase I inhibitor, in therapy-related myelodysplastic syndrome.

Leuk Lymphoma. 2007 Jan;48(1):192-4.

PubMed ID
17325867 [ View in PubMed
]
Abstract

Not Available

DrugBank Data that Cites this Article

Drug Targets
DrugTargetKindOrganismPharmacological ActionActions
EdotecarinDNA topoisomerase 1ProteinHumans
Unknown
Not AvailableDetails